Irritable bowel syndrome: A microbiome-gut-brain axis disorder?
Top Cited Papers
Open Access
- 1 January 2014
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (39) , 14105-14125
Abstract
Irritable bowel syndrome (IBS) is an extremely prevalent but poorly understood gastrointestinal disorder. Consequently, there are no clear diagnostic markers to help diagnose the disorder and treatment options are limited to management of the symptoms. The concept of a dysregulated gut-brain axis has been adopted as a suitable model for the disorder. The gut microbiome may play an important role in the onset and exacerbation of symptoms in the disorder and has been extensively studied in this context. Although a causal role cannot yet be inferred from the clinical studies which have attempted to characterise the gut microbiota in IBS, they do confirm alterations in both community stability and diversity. Moreover, it has been reliably demonstrated that manipulation of the microbiota can influence the key symptoms, including abdominal pain and bowel habit, and other prominent features of IBS. A variety of strategies have been taken to study these interactions, including probiotics, antibiotics, faecal transplantations and the use of germ-free animals. There are clear mechanisms through which the microbiota can produce these effects, both humoral and neural. Taken together, these findings firmly establish the microbiota as a critical node in the gut-brain axis and one which is amenable to therapeutic interventions.Keywords
This publication has 245 references indexed in Scilit:
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosisNature Medicine, 2013
- Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut–brain axisNeuropeptides, 2012
- Regulation of the stress response by the gut microbiota: Implications for psychoneuroendocrinologyPsychoneuroendocrinology, 2012
- Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autismBrain, Behavior, and Immunity, 2012
- New insights into visceral hypersensitivity—clinical implications in IBSNature Reviews Gastroenterology & Hepatology, 2011
- Serotonin receptor diversity in the human colon: Expression of serotonin type 3 receptor subunits 5‐HT3C, 5‐HT3D, and 5‐HT3EJournal of Comparative Neurology, 2010
- Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43Nature, 2009
- Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: Possible anatomical substrates for viscerosensory modulation of exploratory behaviorBrain, Behavior, and Immunity, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- Antimicrobial activity of psychotropic drugsInternational Journal of Antimicrobial Agents, 2000